Company: BWXT
Filing Date: 2025-03-19
Form Type: 10-K/A
Source: 0001486957-25-000015
Chunk: 80

Company: BWX Technologies, Inc.
Filing Date: 2025-03-19
Form: 10-K/A
Chunk 80
---
 expected to be received based on current rights and obligations under the contract, including modifications that were agreed upon with the customer.

◦ Tested the mathematical accuracy of management’s calculation of the profit margin and the revenue recognized based on the costs incurred during the year, consistent with the cost-plus fixed fee nature of the contract.

/S/ DELOITTE & TOUCHE LLP

Charlotte, North Carolina

February 24, 2025

We have served as the Company's auditor since 2009.

<div align='center'>45</div>

#### BWX TECHNOLOGIES, INC.

### CONSOLIDATED STATEMENTS OF INCOME
|                                                                 |     | Year Ended December 31,                           |       2024 |     |   |       2023 |     |   |       2022 |
|:----------------------------------------------------------------|:----|:--------------------------------------------------|-----------:|:----|:--|-----------:|:----|:--|-----------:|
|                                                                 |     | -In thousands, except share and per share amounts |            |     |   |            |     |   |            |
| Revenues                                                        |     | $                                                 |  2,703,654 |     | $ |  2,496,309 |     | $ |  2,232,834 |
| Costs and Expenses:                                             |     |                                                   |            |     |   |            |     |   |            |
| Cost of operations                                              |     |                                                   |  2,048,447 |     |   |  1,875,716 |     |   |  1,680,899 |
| Research and development costs                                  |     |                                                   |      7,478 |     |   |      7,613 |     |   |      9,535 |
| Losses on asset disposals and impairments, net                  |     |                                                   |      4,390 |     |   |      1,034 |     |   |      5,520 |
| Selling, general and administrative expenses                    |     |                                                   |    318,663 |     |   |    279,694 |     |   |    234,282 |
| Total Costs and Expenses                                        |     |                                                   |  2,378,978 |     |   |  2,164,057 |     |   |  1,930,236 |
| Equity in Income of Investees                                   |     |                                                   |